Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Concin

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 30, 2019
Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statementDenis Querleu, David Cibula, Nicole Concin, et al.
Histopathology|July 15, 2018
Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survivalSilvia Darb-Esfahani, Ivonne Kolaschinski, Fabian Trillsch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 21, 2021
Response to: Correspondence on "ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors" by Thomassin-Nagarra et alDirk Timmerman, David Cibula, François Planchamp, et al.
Journal of Cancer Research and Clinical Oncology|February 28, 2019
Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) ConsortiumJun Guan, Silvia Darb-Esfahani, Rolf Richter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2021
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumorsDirk Timmerman, François Planchamp, Tom Bourne, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2022
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational studyMajdi Imterat, Nicolò Bizzarri, Robert Fruscio, et al.
NPJ Genomic Medicine|April 28, 2022
Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancerAdriaan Vanderstichele, Pieter Busschaert, Chiara Landolfo, et al.
Leukemia|May 7, 2024
Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
Oncogene|July 4, 2023
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortiumNicole Heinzl, Elisabeth Maritschnegg, Katarzyna Koziel, et al.
Leukemia|April 18, 2024
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 30, 2019
Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statementDenis Querleu, David Cibula, Nicole Concin, et al.
Histopathology|July 15, 2018
Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survivalSilvia Darb-Esfahani, Ivonne Kolaschinski, Fabian Trillsch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 21, 2021
Response to: Correspondence on "ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors" by Thomassin-Nagarra et alDirk Timmerman, David Cibula, François Planchamp, et al.
Journal of Cancer Research and Clinical Oncology|February 28, 2019
Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) ConsortiumJun Guan, Silvia Darb-Esfahani, Rolf Richter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2021
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumorsDirk Timmerman, François Planchamp, Tom Bourne, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2022
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational studyMajdi Imterat, Nicolò Bizzarri, Robert Fruscio, et al.
NPJ Genomic Medicine|April 28, 2022
Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancerAdriaan Vanderstichele, Pieter Busschaert, Chiara Landolfo, et al.
Leukemia|May 7, 2024
Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
Oncogene|July 4, 2023
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortiumNicole Heinzl, Elisabeth Maritschnegg, Katarzyna Koziel, et al.
Leukemia|April 18, 2024
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
Pageof 14